Supply Chain

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Latest report indicates that air cargo demand is outperforming pre-Covid stats from 2019

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Approval is for the 50-µg dosage

Four trends shaping healthcare in 2022 and beyond

How AI-powered support automation can solve the data problem in clinical trial management

Ongoing strides in data mining, data analytics, modeling and simulation are opening up new and more definitive opportunities to apply data-driven insights to improve everything from upstream drug discovery and clinical trials, to the downstream go-to-market strategy and post-patent lifecycle management

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum

PBM fees and vertical integration are also at the top of the list

Partnership further increases investment firm’s repertoire in healthcare space

Boston area facility will focus heavily on cold chain services

Parties expect improved design and selection of eCOAs in decentralized clinical trials

Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints

Centers for Disease Control and Prevention endorses Pfizer-BioNTech jab, less than two months after firms presented positive study results

Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023

Anticipated capacity of GMP facility is 60 million vials per year

A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022

Award will support research based on use of real-world evidence in clinical oncology setting

Facility features cell storage for CAR-T cell treatments

mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year

As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits

Italian facilities will supply EU with up to 85 million doses of Covid jab

Exploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US

Non-profit strives for pharma supply chain sustainability

Deal is expected to boost manufacturer’s European presence, Aceto executives say

The pandemic has accelerated the adoption of enterprise resource planning in pharma supply chain management, as the recent US rise of one “technology enabler” attests

Via its supply chain network, drug wholesaler has helped deliver more than 75 million vaccines

Marken/UPS, LifeScience Logistics and Packaging Technology Group are among the latest contenders

Previous merger earns clinical research company $235 million as it looks to advance patient enrollment